The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...
A randomized controlled trial in adults with chronic migraine found that 4 weeks of noninvasive vagal nerve stimulation (nVNS) significantly reduced pain intensity, headache frequency, and migraine-related...
Migraine is highly prevalent among women of reproductive age, yet data on real-world medication use around conception remain limited. A new Danish study describes patterns of antimigraine medication use...
A post-hoc analysis of the phase 3 REGAIN trial evaluated whether preventive treatment with galcanezumab could shift patients with chronic migraine to episodic migraine frequency, a clinically meaningful...
